Join Cameron English and Dr. Chuck Dinerstein on Episode 136 of the Science Dispatch podcast as they tackle the ethics of drug advertising.
Drugs & Pharmaceuticals
This is the video version of a recent article penned by Dr. Dinerstein. You can read it here.
Join Cameron English and Dr. Chuck Dinerstein on Episode 131 of the Science Dispatch podcast as they discuss:
Politicians love a health crisis that makes for scary headlines, especially when the danger is insignificant or altogether absent.
As difficult as it is to believe, we are still having a debate about thimerosal, thanks to vaccine "skeptic" Robert F. Kennedy Jr., who is the head of HHS.
It's no secret that I'm not a big fan of Tylenol.
Semaglutide, the GLP-1 better known by its brand name Ozempic, has revolutionized the fight against obesity.
Chronic pain affects more patients than cancer, cardiovascular disease (CVD) and diabetes combined.
